The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pediatric Vaccines-Global Market Insights and Sales Trends 2024

Pediatric Vaccines-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1830492

No of Pages : 125

Ask Your Query
Synopsis
The global Pediatric Vaccines market size is expected to reach US$ 45100 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Vaccines in various end use industries. The expanding demands from the Newborn, Infant, Child and Dolescent, are propelling Pediatric Vaccines market. Diphtheria, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Influenza segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Vaccines covered in this report include GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic and Baxter, etc.
The global Pediatric Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
Global Pediatric Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Vaccines market, Segment by Type:
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others
Global Pediatric Vaccines market, by Application
Newborn
Infant
Child
Dolescent
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pediatric Vaccines Market Overview
1.1 Pediatric Vaccines Product Overview
1.2 Pediatric Vaccines Market Segment by Type
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Others
1.3 Global Pediatric Vaccines Market Size by Type
1.3.1 Global Pediatric Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Pediatric Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pediatric Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pediatric Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Type (2018-2023)
2 Global Pediatric Vaccines Market Competition by Company
2.1 Global Top Players by Pediatric Vaccines Sales (2018-2023)
2.2 Global Top Players by Pediatric Vaccines Revenue (2018-2023)
2.3 Global Top Players by Pediatric Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Pediatric Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Vaccines Market
2.8 Key Manufacturers Pediatric Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Vaccines Status and Outlook by Region
3.1 Global Pediatric Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pediatric Vaccines Historic Market Size by Region
3.2.1 Global Pediatric Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Pediatric Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Pediatric Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pediatric Vaccines Forecasted Market Size by Region
3.3.1 Global Pediatric Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Pediatric Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Pediatric Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pediatric Vaccines by Application
4.1 Pediatric Vaccines Market Segment by Application
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.1.4 Dolescent
4.2 Global Pediatric Vaccines Market Size by Application
4.2.1 Global Pediatric Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Pediatric Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pediatric Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pediatric Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Application (2018-2023)
5 North America Pediatric Vaccines by Country
5.1 North America Pediatric Vaccines Historic Market Size by Country
5.1.1 North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pediatric Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Pediatric Vaccines Sales in Value by Country (2018-2023)
5.2 North America Pediatric Vaccines Forecasted Market Size by Country
5.2.1 North America Pediatric Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Pediatric Vaccines Sales in Value by Country (2024-2029)
6 Europe Pediatric Vaccines by Country
6.1 Europe Pediatric Vaccines Historic Market Size by Country
6.1.1 Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pediatric Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Pediatric Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Pediatric Vaccines Forecasted Market Size by Country
6.2.1 Europe Pediatric Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Pediatric Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Pediatric Vaccines by Region
7.1 Asia-Pacific Pediatric Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pediatric Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2024-2029)
8 Latin America Pediatric Vaccines by Country
8.1 Latin America Pediatric Vaccines Historic Market Size by Country
8.1.1 Latin America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pediatric Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pediatric Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Pediatric Vaccines Forecasted Market Size by Country
8.2.1 Latin America Pediatric Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pediatric Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Pediatric Vaccines by Country
9.1 Middle East and Africa Pediatric Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pediatric Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Pediatric Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Pediatric Vaccines Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Pediatric Vaccines Products Offered
10.4.5 Sanofi Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Pediatric Vaccines Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Pediatric Vaccines Products Offered
10.6.5 Novartis Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Bavarian Nordic Introduction and Business Overview
10.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
10.8.5 Bavarian Nordic Recent Development
10.9 Baxter
10.9.1 Baxter Company Information
10.9.2 Baxter Introduction and Business Overview
10.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Baxter Pediatric Vaccines Products Offered
10.9.5 Baxter Recent Development
10.10 LG Life Sciences
10.10.1 LG Life Sciences Company Information
10.10.2 LG Life Sciences Introduction and Business Overview
10.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 LG Life Sciences Pediatric Vaccines Products Offered
10.10.5 LG Life Sciences Recent Development
10.11 Lupin
10.11.1 Lupin Company Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lupin Pediatric Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 S K Chemicals
10.12.1 S K Chemicals Company Information
10.12.2 S K Chemicals Introduction and Business Overview
10.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 S K Chemicals Pediatric Vaccines Products Offered
10.12.5 S K Chemicals Recent Development
10.13 Mitsubishi Tanabe Pharma
10.13.1 Mitsubishi Tanabe Pharma Company Information
10.13.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products Offered
10.13.5 Mitsubishi Tanabe Pharma Recent Development
10.14 Janssen
10.14.1 Janssen Company Information
10.14.2 Janssen Introduction and Business Overview
10.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Janssen Pediatric Vaccines Products Offered
10.14.5 Janssen Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Company Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Company Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Sinovac Biotech Pediatric Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Bharat Biotech
10.17.1 Bharat Biotech Company Information
10.17.2 Bharat Biotech Introduction and Business Overview
10.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Bharat Biotech Pediatric Vaccines Products Offered
10.17.5 Bharat Biotech Recent Development
10.18 Crucell
10.18.1 Crucell Company Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Crucell Pediatric Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Dynavax
10.19.1 Dynavax Company Information
10.19.2 Dynavax Introduction and Business Overview
10.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Dynavax Pediatric Vaccines Products Offered
10.19.5 Dynavax Recent Development
10.20 Serum Institute of India
10.20.1 Serum Institute of India Company Information
10.20.2 Serum Institute of India Introduction and Business Overview
10.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Serum Institute of India Pediatric Vaccines Products Offered
10.20.5 Serum Institute of India Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Vaccines Industrial Chain Analysis
11.4 Pediatric Vaccines Market Dynamics
11.4.1 Pediatric Vaccines Industry Trends
11.4.2 Pediatric Vaccines Market Drivers
11.4.3 Pediatric Vaccines Market Challenges
11.4.4 Pediatric Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Vaccines Distributors
12.3 Pediatric Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock